How to use Technologies offered

A search for a cancer, preclinical stage, synthetic opportunity would use the selection "Therapeutics, Diagnostics" in 'Sector', 'Cancerous, neoplasmatic' in 'Disease Category', 'Drugs, Small Molecule' in 'Technology' and 'Preclinical' in 'Development Stage'.

Selection of 'Enabling Technology, Platform Technology' in 'Sector' will identify all kinds of research technologies that can be used in more areas of life sciences than pharmaceuticals only.

Each technology profile gives the name of a company or academic institute as source of the offer, and a link allowing to contact the potential licensor. In most cases a profile includes a pdf covering the available non-confidential information as well as detailed contact data.

Registered users can create non-public notifications profiles which will inform them about new 'Technologies Offered' entries fitting their needs as specified. In addition these profiles allow them to filter the available information more comfortably.


New Genetic Test for Shar-Pei Autoinflammatory Disease (SPAID)

Organization name

MBM ScienceBridge GmbH


SPAID is a spontaneously occurring autoinflammatory disease in Shar-Pei dogs. It is characterized by recurrent signs of inflammation like fever, swollen joints, reddened skin, ear problems, arthritis. SPAID can even lead to amyloidosis and kidney failure. The dogs with SPAID may experience one or more of these problems.


SPAID is a severe genetic disease in Shar-Pei which cannot be cured and results in serious and persistent signs in affected dogs. Without the knowledge of the pathomechanism of the autoinflammatory process, therapeutic options cannot be developed.
The previously offered genetic testing method for an SPAID-associated mutation is a complex and expensive procedure and does not provide a functional explanation for disease development.

Our Solution

Scientists at the University of Veterinary Medicine Hannover developed a new genetic test for a functional mutation
which triggers SPAID in Shar-Pei dogs. Variant detection is performed using a cost-effective detection method and
thereby provides an efficient tool for breeders to do genetic testing for SPAID in their dogs to enable targeted
breeding decisions.


  • Identification of a new genetic test responsible for SPAID.
  • Genetic variant can be detected using simple and inexpensive method.
  • Dogs can be tested at any age.
  • Confidence and assurance for dog breeders for targeted breeding decisions.


Genetic test for SPAID predisposition in Shar-Pei (diagnostics).

Developmental Status

The genetic test has been successfully tested and validated for Shar-Pei EDTA-stabilized blood samples.

Patent Status

A European patent application has been filed (Applicant: University of Veterinary Medicine Hannover, Foundation, Germany).

To view the contact information, attachments and url of this profile you have to login into your account or register a new account: Login Register

Your feedback

Please click here to log in to view the complete profile.


latest entries